1. Long-term neurocognitive and quality of life outcomes in survivors of pediatric hematopoietic cell transplant
- Author
-
Stephanie J. Lee, Nina S. Kadan-Lottick, Eric J. Chow, Nicole J. Ullrich, Natalie L Wu, Kevin R. Krull, and Kara L. Cushing-Haugen
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pediatrics ,Population ,Standard score ,Article ,03 medical and health sciences ,Cognition ,0302 clinical medicine ,Quality of life ,Surveys and Questionnaires ,medicine ,Humans ,Survivors ,030212 general & internal medicine ,Child ,education ,Stroke ,education.field_of_study ,Oncology (nursing) ,business.industry ,Public health ,Hematopoietic Stem Cell Transplantation ,Middle Aged ,medicine.disease ,Oncology ,030220 oncology & carcinogenesis ,Cohort ,Quality of Life ,Female ,business ,Neurocognitive - Abstract
PURPOSE: Pediatric patients who undergo hematopoietic cell transplant (HCT) are at risk for neurocognitive impairments, which can impact quality of life. Given limited long-term studies, we aimed to characterize the late neurocognitive outcomes in a cohort of pediatric HCT survivors. METHODS: Eligible survivors (HCT at age 1.28) in task efficiency, memory, emotional regulation, or organization, compared with expected 10% in the general population (all p
- Published
- 2021